GemPharmatech

GemPharmatech is a biotechnology firm that focuses on the generation and distribution of genome-modified mouse and immune-checkpoint models. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

GemPharmatech

GemPharmatech is a biotechnology firm that focuses on the generation and distribution of genome-modified mouse and immune-checkpoint models. Read more

Xiang Gao's photo - President of GemPharmatech

President

Xiang Gao

CEO Approval Rating

87/100

Founded:

2017

Status:

PrivateIndependent Company

GEMPHARMATECH TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Taconic Biosciences, Inc. is one of GemPharmatech's top rivals. Taconic Biosciences, Inc. was founded in Rensselaer, New York} in 1952. Like GemPharmatech, Taconic Biosciences, Inc. also competes in the Medical Research & Laboratories space. Compared to GemPharmatech, Taconic Biosciences, Inc. generates $225M more revenue.

Cyagen is GemPharmatech's #2 competitor. Cyagen was founded in 2006, and is headquartered in Santa Clara, California. Like GemPharmatech, Cyagen also operates in the Medical Research & Laboratories space. Cyagen generates $24.8M less revenue vs. GemPharmatech.

Biocytogen is a top competitor of GemPharmatech. Biocytogen's headquarters is in Wakefield, Massachusetts, and was founded in 2008. Like GemPharmatech, Biocytogen also works within the Medical Research & Laboratories sector. Biocytogen generates 40% of GemPharmatech's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 500 a good estimate for GemPharmatech's Employee count?

GemPharmatech Acquisitions

No recent acquisitions found related to GemPharmatech

GemPharmatech Funding History

$23.2M$81.7M

Since GemPharmatech was founded in 2017, it has participated in 2 rounds of funding. In total GemPharmatech has raised $81.7M. GemPharmatech's last funding round was on Sep 2020 for a total of $58.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Sep 2020
$58.5M
Series A
May 2019
$23.2M

CDH Investments

Since GemPharmatech was founded in 2017, it has participated in 2 rounds of funding. In total GemPharmatech has raised $81.7M. GemPharmatech's last funding round was on Sep 2020 for a total of $58.5M

GemPharmatech Investments

No recent investments found related to GemPharmatech

GemPharmatech Press Releases

Social Media

GemPharmatech Headquarters

12 Xuefu Road

Nanjing, Jiangsu Province210061

025-5864-1508

Driving Directions »

Trending Companies

GemPharmatech Summary

ABOUT

Overview

GemPharmatech is a biotechnology firm that focuses on the generation and distribution of genome-modified mouse and immune-checkpoint models. GemPharmatech was founded in 2017. GemPharmatech's headquarters is located in Nanjing, Jiangsu Province, CN 21...

CEO

GemPharmatech's President, Xiang Gao, currently has an approval rating of 87%. GemPharmatech's primary competitors are Taconic Biosciences, Inc., Cyagen & Biocytogen.

Website

gempharmatech.com

Frequently Asked Questions about GemPharmatech

  1. When was GemPharmatech founded?

    GemPharmatech was founded in 2017
  2. Who is GemPharmatech's CEO?

    GemPharmatech's CEO is Xiang Gao
  3. How much revenue does GemPharmatech generate?

    GemPharmatech generates $30M in revenue
  4. How much funding does GemPharmatech have?

    GemPharmatech has historically raised $81.7M in funding
  1. Where is GemPharmatech's headquarters?

    GemPharmatech's headquarters is in Nanjing Jiangsu Province, CN
  2. How many employees does GemPharmatech have?

    GemPharmatech has 500 employees
  3. What sector does GemPharmatech operate in?

    GemPharmatech is in Medical Research & Laboratories, Biotechnology
  4. Who are GemPharmatech's competitors?

    GemPharmatech's top competitors are Taconic Biosciences, Inc., Cyagen, Biocytogen